Annual Review of the Rationale for Holding Cross-Shareholdings
First written in FY2019. . Latest entry: FY2026.
- FY2026Update to holdings and acquisition informationAnnual report
「Shares other than unlisted shares 2 92,434 (Issues for which the number of shares increased during the fiscal year) Shares other than unlisted shares 2 3,960 Regular purchases through the employee stock ownership plan」
The Company's cross-shareholdings comprised 2 listed issues, with a balance-sheet carrying amount of ¥92,434 thousand. The number of shares in both issues increased through regular purchases under the employee stock ownership plan. - FY2025Update to holding amounts and issue informationAnnual report
「Shares other than unlisted shares 2 89,928 (Issues for which the number of shares increased during the fiscal year) Shares other than unlisted shares 2 3,533 Regular purchases through the employee stock ownership plan」
The Company's cross-shareholdings comprised 2 listed issues, with a balance-sheet carrying amount of ¥89,928 thousand. The number of shares increased for both issues through regular purchases under the employee stock ownership plan. - FY2024Update to holdings and employee stock ownership plan purchasesAnnual report
「Shares other than unlisted shares 2 101,074 (Issues for which the number of shares increased during the fiscal year) Shares other than unlisted shares 2 3,079 Regular purchases through the employee stock ownership plan」
For the cross-shareholdings for which the previous disclosure reported the sale of 日医工 shares, the Company held 2 listed issues at fiscal year-end, with a total balance-sheet carrying amount of ¥101,074 thousand. The number of shares increased for both issues through regular purchases under the employee stock ownership plan. - FY2023Sale of holdingsAnnual report
「During the fiscal year, the Company sold all shares other than less-than-one-trading-unit shares. The less-than-one-trading-unit shares were also removed from specified investment shares because the company concerned delisted its shares.」
The Company states that it sold all shares of 日医工 other than its less-than-one-trading-unit shares and removed its shares from specified investment shares. - FY2021Addition of acquisition review criteriaAnnual report
「When acquiring shares, the Company conducts a detailed review for each issue of the significance and rationale of acquiring and holding the shares, as well as their profitability and reasonableness in light of the cost of capital and other factors, based on the policy above, and submits the matter for resolution by the Board of Directors.」
In addition to the annual review of the appropriateness of cross-shareholdings, the Company explicitly states that it will review the purpose of new acquisitions, the cost of capital, profitability and reasonableness, and obtain a resolution by the Board of Directors. - FY2019First statedAnnual report
「The Company plans to continue holding shares that it deems necessary after comprehensively considering their strategic importance to the business and business relationships with counterparties, and reports the results of its annual review of whether each holding remains appropriate.」
The Company states that it will review and report annually on the appropriateness of its holdings of cross-shareholdings, taking into account their strategic importance and business relationships.